Jason Bednar
Stock Analyst at Piper Sandler
(2.14)
# 2,844
Out of 5,182 analysts
208
Total ratings
38.06%
Success rate
-3.93%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Maintains: Overweight | $220 → $235 | $184.70 | +27.23% | 34 | Apr 21, 2026 | |
| SOLV Solventum | Maintains: Overweight | $98 → $92 | $69.78 | +31.84% | 9 | Apr 17, 2026 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $96 | $67.43 | +42.37% | 16 | Apr 17, 2026 | |
| ICUI ICU Medical | Maintains: Overweight | $178 → $163 | $122.85 | +32.68% | 5 | Apr 17, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $96 → $88 | $70.48 | +24.86% | 3 | Apr 17, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Neutral | $170 → $159 | $150.22 | +5.84% | 14 | Apr 17, 2026 | |
| DRTS Alpha Tau Medical | Downgrades: Neutral | $5 | $7.91 | -36.79% | 6 | Mar 4, 2026 | |
| NVST Envista Holdings | Reiterates: Neutral | $21 → $25 | $26.77 | -6.61% | 15 | Feb 6, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $45.23 | +10.55% | 1 | Jan 12, 2026 | |
| SHC Sotera Health Company | Upgrades: Overweight | $17 → $24 | $15.81 | +51.80% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $83 → $94 | $64.34 | +46.10% | 15 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $4 | $4.06 | -1.48% | 8 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $210 | $178.66 | +17.54% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $9 → $2.5 | $1.28 | +95.31% | 12 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $34 | $12.48 | +172.44% | 11 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $11.96 | +33.78% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $77.20 | -0.26% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $3.22 | +39.75% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $222.19 | +19.27% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $2.04 | +194.12% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $20 | $0.49 | +4,005.93% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $470.99 | -21.02% | 4 | Jan 3, 2024 |
Align Technology
Apr 21, 2026
Maintains: Overweight
Price Target: $220 → $235
Current: $184.70
Upside: +27.23%
Solventum
Apr 17, 2026
Maintains: Overweight
Price Target: $98 → $92
Current: $69.78
Upside: +31.84%
Merit Medical Systems
Apr 17, 2026
Maintains: Overweight
Price Target: $106 → $96
Current: $67.43
Upside: +42.37%
ICU Medical
Apr 17, 2026
Maintains: Overweight
Price Target: $178 → $163
Current: $122.85
Upside: +32.68%
GE HealthCare Technologies
Apr 17, 2026
Maintains: Overweight
Price Target: $96 → $88
Current: $70.48
Upside: +24.86%
Becton, Dickinson and Company
Apr 17, 2026
Maintains: Neutral
Price Target: $170 → $159
Current: $150.22
Upside: +5.84%
Alpha Tau Medical
Mar 4, 2026
Downgrades: Neutral
Price Target: $5
Current: $7.91
Upside: -36.79%
Envista Holdings
Feb 6, 2026
Reiterates: Neutral
Price Target: $21 → $25
Current: $26.77
Upside: -6.61%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $45.23
Upside: +10.55%
Sotera Health Company
Jan 9, 2026
Upgrades: Overweight
Price Target: $17 → $24
Current: $15.81
Upside: +51.80%
Dec 5, 2025
Reiterates: Overweight
Price Target: $83 → $94
Current: $64.34
Upside: +46.10%
Aug 7, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $4.06
Upside: -1.48%
Aug 6, 2025
Maintains: Overweight
Price Target: $200 → $210
Current: $178.66
Upside: +17.54%
Jul 31, 2025
Downgrades: Neutral
Price Target: $9 → $2.5
Current: $1.28
Upside: +95.31%
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $12.48
Upside: +172.44%
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $11.96
Upside: +33.78%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $77.20
Upside: -0.26%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $3.22
Upside: +39.75%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $222.19
Upside: +19.27%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $2.04
Upside: +194.12%
Aug 7, 2024
Maintains: Overweight
Price Target: $70 → $20
Current: $0.49
Upside: +4,005.93%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $470.99
Upside: -21.02%